HappeningToo topic
Ixazomib reports
Browse community reports connected to Ixazomib. These reports can show that other people are describing similar experiences, but they do not prove that Ixazomib caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
32 problems
Abdominal Discomfort while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and abdominal discomfort appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and abdominal pain upper appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and abdominal pain appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and back pain appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and constipation appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and cough appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and decreased appetite appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and dehydration appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and diarrhea appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and dizziness appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Skin while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and dry skin appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and fatigue appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and feeling abnormal appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and headache appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and hypotension appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and insomnia appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and itching appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and malaise appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and muscle spasms appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and nausea appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and pain appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and peripheral swelling appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and rash appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and shortness of breath appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and sleepiness appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and tingling or pins and needles appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and tremor appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and vision blurred appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and vomiting appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and weakness appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and weight decreased appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Ixazomib
FDA FAERS contains adverse-event reports in which Ixazomib and weight increased appear together. This does not establish that Ixazomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →